Hans Edgar Bishop
CIK 1480212 · CEO & President · last filed 2026-07-07
Hans Edgar Bishop is a CEO & President who has filed 72 SEC Form 4 insider transactions across 6 companies since 2012. The most recent filing, for SANA, was dated Jul 7, 2026. Across all open-market trades the lifetime net is −$34.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $28.3M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$28.32M
6
72
-$34.48M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SANA | Director | 5,854,800 | $3.68 | $21.55M | $0 | 27 | 2026-07-07 |
| LYEL | Director | 234,281 | $13.55 | $3.17M | $0 | 7 | 2024-06-17 |
| A | Director | 24,226 | $148.45 | $3.60M | $0 | 9 | 2024-03-19 |
| CELGENE CORP /DE/ (CELGZ) Delisted | Director | 0 | — | — | $0 | 3 | 2019-11-22 |
| Juno Therapeutics, Inc. (JUNO) Delisted | CEO & President | 135,452 | — | — | -$34.48M | 17 | 2018-03-07 |
| AVANIR PHARMACEUTICALS, INC. (AVNR) Delisted | Director | 93,350 | — | — | $0 | 3 | 2014-02-14 |
Recent Filings
72 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-07-07 | SANA | Grant (A) | +6,297 | $0 | EDGAR |
| 2026-06-05 | SANA | Grant (A) | — | $0 | EDGAR |
| 2026-04-08 | SANA | Grant (A) | +7,763 | $0 | EDGAR |
| 2026-01-06 | SANA | Grant (A) | +6,157 | $0 | EDGAR |
| 2025-10-07 | SANA | Grant (A) | +5,628 | $0 | EDGAR |
| 2025-07-08 | SANA | Grant (A) | +7,842 | $0 | EDGAR |
| 2025-06-09 | SANA | Grant (A) | — | $0 | EDGAR |
| 2025-04-08 | SANA | Grant (A) | +16,339 | $0 | EDGAR |
| 2025-01-07 | SANA | Grant (A) | +14,285 | $0 | EDGAR |
| 2024-10-09 | SANA | Grant (A) | +5,938 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.